Rodrigo G. Taboada
Agulha, SP, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Cost savings associated with the adoption of lower-dose everolimus in patients with advanced neuroendocrine tumors.
Journal: ESMO gastrointestinal oncology
Published: May 29, 2026
Neoadjuvant radiotherapy after chemotherapy does not improve surgical or survival outcomes in borderline resectable pancreatic cancer.
Journal: Journal of gastrointestinal oncology
Published: December 15, 2025
Alkylating-induced hypermutation in pancreatic neuroendocrine tumours.
Journal: BMJ oncology
Published: July 28, 2025
Pancreatic Ductal Adenocarcinoma with Medullary Features and a Complete Pathological Response After Neoadjuvant FOLFIRINOX: A Case Report and Literature Review.
Journal: Journal of gastrointestinal cancer
Published: November 07, 2024
The Efficacy of a Lower Dose of Everolimus in Patients with Advanced Neuroendocrine Tumors.
Journal: Cancers
Published: September 29, 2024
Tyrosine kinase inhibitors in patients with neuroendocrine neoplasms: a systematic literature review.
Journal: Therapeutic advances in medical oncology
Published: April 24, 2024
Differentiating high-grade neuroendocrine neoplasms.
Journal: Nature reviews. Cancer
Published: January 30, 2024
Survival trends in gastric cancer in Brazil: real-life data from a large cancer center.
Journal: Ecancermedicalscience
Published: December 16, 2023
Loss of CDX2 and high COX2 (PTGS2) expression in metastatic colorectal cancer.
Journal: Ecancermedicalscience
Published: September 20, 2023
Therapy Sequencing in Patients With Advanced Neuroendocrine Neoplasms.
Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
Published: May 31, 2023
HORMONET: a phase II trial of tamoxifen for estrogen/progesterone receptor-positive neuroendocrine tumors.
Journal: Therapeutic advances in medical oncology
Published: December 19, 2022
Clinicopathological and molecular profile of grade 3 gastroenteropancreatic neuroendocrine neoplasms.
Journal: Journal of neuroendocrinology
Published: September 30, 2021
Last Updated: 09/26/2026